Poetra.RH / Shutterstock.com

8 August 2024NewsAmericasMuireann Bolger

Pfizer fends off misconduct claims to keep $107.5m award

A Delaware jury found AstraZeneca liable for induced infringement of a cancer treatment in May | Pharma company levelled allegations of "unclean hands" and "patent misuse" at Pfizer unit.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

HLK adds CRISPR specialist as partner

Novo Nordisk files fresh lawsuits to intercept Wegovy generics

UPC delivers first 'imminent infringement' decision in biosimilar dispute

AstraZeneca unit draws line under Samsung dispute

Brown Rudnick expands with new partner duo

UPC: First decisions on merits are ‘testimony to judges’ tight case management’

Morgan Lewis adds two partners to London office

UK firm prevails in ‘exceptionally slow’ UPC test case